Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24weeks
Just $1.99 per week for the first 24weeks
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24weeks

var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 133.03
Day High 142.80
Open:135.35
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

COVID-19 Pandemic in the US May Curtail Uptake of Recent Acute Migraine Market Entrants, Diminishing Specialists' Prelaunch Expectations that Biohaven's Nurtec ODT Would Challenge Allergan's Ubrelvy and Eli Lilly's Reyvow
- PR Newswire - Thu Apr 2, 7:00AM CDT
PR Newswire - CMTX
Thu Apr 2, 7:00AM CDT
Biohaven's Nurtec (rimegepant) orally disintegrating tablet (ODT), a calcitonin gene-related peptide (CGRP) receptor antagonist, was approved by the FDA for the acute treatment of migraine in adults on February 27th and commercially launched on March 12th. Fielded between February 6th and 19th, data from 98 migraine specialists and neurologists surveyed as part of the ongoing quarterly report series included in Spherix's RealTime Dynamix(TM): Migraine (US) service, found that Nurtec ODT was poised for a strong launch, based upon a broad early prescriber base and a sizeable candidate pool.
Acute Otitis Media Treatment Market Insights By Size, Share, Future Growth And Forecast From 2019-2029
- AmericaNewsHour - Thu Apr 2, 5:38AM CDT
AmericaNewsHour - CMTX
Thu Apr 2, 5:38AM CDT
The research study on Global Acute Otitis Media Treatment market 2019 presents an extensive analysis of current Acute Otitis Media Treatment market size, drivers, trends, opportunities, challenges, as well as key Acute Otitis Media Treatment market segments. Further, it explains various definitions and classification of the Acute Otitis Media Treatment industry, applications, and chain structure.In continuation of this data, the Acute Otitis Media Treatment report covers various marketing strategies followed by key players and distributors. Also explains Acute Otitis Media Treatment marketing channels, potential buyers and development history. The intent of global Acute Otitis Media Treatment research report is to depict the information to the user regarding Acute Otitis Media Treatment market forecast and dynamics for the upcoming years.The Acute Otitis Media Treatment study lists the essential elements which influence the growth of Acute Otitis Media Treatment industry. Long-term evaluation of the worldwide Acute Otitis Media Treatment market share from diverse countries and regions is roofed within the Acute Otitis Media Treatment report. Additionally, includes Acute Otitis Media Treatment type wise and application wise consumption figures.Download Sample of This Strategic Report: After the basic information, the global Acute Otitis Media Treatment Market study sheds light on the Acute Otitis Media Treatment technological evolution, tie-ups, acquisition, innovative Acute Otitis Media Treatment business approach, new launches and Acute Otitis Media Treatment revenue. In addition, the Acute Otitis Media Treatment industry growth in distinct regions and Acute Otitis Media Treatment R&D status are enclosed within the report.The Acute Otitis Media Treatment study also incorporates new investment feasibility analysis of Acute Otitis Media Treatment. Together with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities, and challenges in the Acute Otitis Media Treatment market.Global Acute Otitis Media Treatment Market Segmentation 2019:The study also classifies the entire Acute Otitis Media Treatment market on basis of leading manufacturers, different types, various applications and diverse geographical regions.Overall Acute Otitis Media Treatment market is characterized by the existence of well-known global and regional Acute Otitis Media Treatment vendors. These established Acute Otitis Media Treatment players have huge essential resources and funds for Acute Otitis Media Treatment research as well as developmental activities. Also, the Acute Otitis Media Treatment manufacturers focusing on the development of new Acute Otitis Media Treatment technologies and feedstock. In fact, this will enhance the competitive scenario of the Acute Otitis Media Treatment industry.The Leading Players involved in global Acute Otitis Media Treatment market are:Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb CompanyBased on Drug Class, the Acute Otitis Media Treatment market is categorized into: Antibiotics, Nonsteroidal anti-Inflammatory drug, Analgesic, and AnestheticBased on Formulation, the Acute Otitis Media Treatment market is categorized into: Oral and TopicalBased on Distribution Channel, the Acute Otitis Media Treatment market is categorized into: Hospitals, Retail Pharmacies, and Online PharmaciesGlobal Acute Otitis Media Treatment Market Regional Analysis:The companies in the world that deals with Acute Otitis Media Treatment mainly concentrate following regions.North America, Europe, Asia Pacific, Latin America, and Middle East & AfricaGlobal Acute Otitis Media Treatment Industry Report Covers following Topics:01: Acute Otitis Media Treatment Market Overview02: Global Acute Otitis Media Treatment Sales, Revenue (value) and Market Share by Players03: Acute Otitis Media Treatment Market Sales, Revenue (Value) by Regions, Type and Application (2014-2018)04: Region wise Top Players Acute Otitis Media Treatment Sales, Revenue and Price05: worldwide Acute Otitis Media Treatment Industry Players Profiles/Analysis06: Acute Otitis Media Treatment Manufacturing Cost Analysis07: Industrial Chain, Acute Otitis Media Treatment Sourcing Strategy and Downstream Buyers08: Acute Otitis Media Treatment Marketing Strategy Analysis, Distributors/Traders09: Acute Otitis Media Treatment Industry Effect Factors Analysis10: Global Acute Otitis Media Treatment Market Forecast (2019-2026)11: Acute Otitis Media Treatment Research Findings and Conclusion12: AppendixDownload Sample of This Strategic Report: Worldwide Acute Otitis Media Treatment Market Different Analysis:Competitors Review of Acute Otitis Media Treatment Market: Report presents the competitive landscape scenario seen among top Acute Otitis Media Treatment players, their company profile, revenue, sales, business tactics and forecast Acute Otitis Media Treatment industry situations.Production Review of Acute Otitis Media Treatment Market: It illustrates the production volume, capacity with respect to major Acute Otitis Media Treatment regions, application, type, and the price.Sales Margin and Revenue Accumulation Review of Acute Otitis Media Treatment Market: Eventually explains sales margin and revenue accumulation based on key regions, price, revenue, and Acute Otitis Media Treatment target consumer.Supply and Demand Review of Acute Otitis Media Treatment Market: Coupled with sales margin, the report depicts the supply and demand seen in major regions, among key players and for every Acute Otitis Media Treatment product type. Also interprets the Acute Otitis Media Treatment import/export scenario.Other key reviews of Acute Otitis Media Treatment Market: Apart from the above information, correspondingly covers the company website, number of employees, contact details of major Acute Otitis Media Treatment players, potential consumers and suppliers. Also, the strengths, opportunities, Acute Otitis Media Treatment market driving forces and market restraints are studied in this report.Highlights of Global Acute Otitis Media Treatment Market Report:* This report provides in detail analysis of the Acute Otitis Media Treatment and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2019 - 2029.* It also elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for world Acute Otitis Media Treatment market.* This study also provides key insights about Acute Otitis Media Treatment market drivers, restraints, opportunities, new product launches, approvals, regional outlook, and competitive strategies adopted by the leading Acute Otitis Media Treatment players.* It profiles leading players in the worldwide Acute Otitis Media Treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.* Insights from Acute Otitis Media Treatment report would allow marketers and management authorities of companies to make an informed decision with respect to their future product launches, market expansion, and Acute Otitis Media Treatment marketing tactics.* The world Acute Otitis Media Treatment industry report caters to various stakeholders in Acute Otitis Media Treatment market. That includes investors, device manufacturers, distributors and suppliers for Acute Otitis Media Treatment equipment. Especially incorporates government organizations, Acute Otitis Media Treatment research and consulting firms, new entrants, and financial analysts.*Various strategy matrices used in analyzing the Acute Otitis Media Treatment market would provide stakeholders vital inputs to make strategic decisions accordingly.Global Acute Otitis Media Treatment Market Report Provides Comprehensive Analysis of Following:- Acute Otitis Media Treatment Market segments and sub-segments- Industry size & Acute Otitis Media Treatment shares- Acute Otitis Media Treatment Market trends and dynamics- Market Drivers and Acute Otitis Media Treatment Opportunities- Supply and demand of world Acute Otitis Media Treatment industry- Technological inventions in Acute Otitis Media Treatment trade- Acute Otitis Media Treatment Marketing Channel Development Trend- Global Acute Otitis Media Treatment Industry Positioning- Pricing and Brand Strategy- Distributors/Traders List enclosed in Positioning Acute Otitis Media Treatment Market.Request For Full Report: Moreover, the report organizes to provide essential information on current and future Acute Otitis Media Treatment market movements, organizational needs and Acute Otitis Media Treatment industrial innovations. Additionally, the complete Acute Otitis Media Treatment report helps the new aspirants to inspect the forthcoming opportunities in the Acute Otitis Media Treatment industry. Investors will get a clear idea of the dominant Acute Otitis Media Treatment players and their future forecasts.
Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic
- BusinessWire - Wed Apr 1, 3:00PM CDT
BusinessWire - CMTX
Wed Apr 1, 3:00PM CDT
Merck & Co., Inc., (NYSE: MRK), Pfizer Inc. (NYSE: PFE), and Eli Lilly and Company (NYSE: LLY) today announced medical service volunteer programs to enable employees who are licensed medical professionals to aid in the fight against COVID-19 while maintaining their base pay.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 117.06 +21.46% increase
on 03/23/20
Period Open:132.84
Price movement based on the high, low and last over the given period.
144.00 -1.26% decrease
on 03/18/20
+9.34 (+7.03%) increase
since 03/02/20
3-Month 117.06 +21.46% increase
on 03/23/20
Period Open:132.21
Price movement based on the high, low and last over the given period.
147.87 -3.85% decrease
on 02/06/20
+9.97 (+7.54%) increase
since 01/02/20
52-Week 101.36 +40.27% increase
on 10/23/19
Period Open:129.32
Price movement based on the high, low and last over the given period.
147.87 -3.85% decrease
on 02/06/20
+12.86 (+9.94%) increase
since 04/02/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies